Type 1 Diabetes Trial, Recruiting NCT06575790 Sponsor: University of Colorado, Denver Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT06575790
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with Type 1 Diabetes for at least 1 year.
  • People who are already using a commercial hybrid closed-loop insulin system (a device that automatically adjusts insulin delivery).
  • People who are willing not to start any new non-insulin blood sugar-lowering medications during the trial.
  • People who are willing to take part in all study procedures.
  • People whom the investigator believes can confidently use all the required study devices and follow the study plan.

Who may not be able to join:

  • People who have had more than one severe low blood sugar episode involving a seizure or loss of consciousness in the last 6 months, or more than one episode of diabetic ketoacidosis (a serious diabetes complication) in the last 6 months that was not caused by illness or an insulin pump delivery failure.
  • People who have a history of chronic kidney disease, are currently on dialysis, have untreated or inadequately treated underactive thyroid or adrenal insufficiency, have used oral or injectable steroids in the last 8 weeks, or are known to have an ongoing intolerance to medical adhesives.
  • People who have any other condition that, in the investigator's judgement, could put them or the study at risk.
  • People who are already taking part in another interventional clinical trial at the time of enrollment.
  • People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 303-724-2323

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 November 2024
Est. completion
30 September 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Time in Range

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov